Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke

Shérine Abboud, Pekka J. Karhunen, Dieter Lütjohann et al. · 2007

Read Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke by Shérine Abboud, Pekka J. Karhunen, Dieter Lütjohann et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001043.txt.

Description

Sherine Abboud, Pekka Karhunen, Dieter Lutjohann and colleagues linked a cholesterol gene to a major stroke type, in PLOS ONE in 2007. The gene PCSK9 helps set blood levels of LDL cholesterol, the harmful kind. Its variants were already tied to cholesterol levels and coronary heart disease severity.

The team asked whether PCSK9 also raises the risk of large vessel atherosclerosis stroke, the kind caused by clogged big arteries. A gene that links cholesterol to stroke as well as heart disease widens the case for targeting it. Drugs against PCSK9 were a live idea at the time. Genetic evidence from patients helps judge that idea.

Catalog record

CREATORShérine Abboud, Pekka J. Karhunen, Dieter Lütjohann et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001043

Browse the full library · About the Tower of Babel